PT  - JOURNAL ARTICLE
AU  - Tania Dehesh
AU  - Heydar Ali Mardani-Fard
AU  - Paria Dehesh
TI  - Predicting of COVID-19 Confirmed Cases in Different Countries with ARIMA Models in 2020
AID  - 10.1101/2020.03.13.20035345
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2020.03.13.20035345
4099  - http://medrxiv.org/content/early/2023/02/08/2020.03.13.20035345.short
4100  - http://medrxiv.org/content/early/2023/02/08/2020.03.13.20035345.full
AB  - The epidemic of a novel coronavirus illness (COVID-19) becomes as a global threat. The aim of this study is first to find the best prediction models for daily confirmed cases in countries with high number of confirmed cases in the world and second to predict confirmed cases with these models in order to have more readiness in healthcare systems. This study was conducted based on daily confirmed cases of COVID-19 that were collected from the official website of Johns Hopkins University from January 22th, 2020 to March 1th, 2020. Auto Regressive Integrated Moving Average (ARIMA) model was used to predict the trend of confirmed cases. Stata version 12 and R version 3.6.2 were used. Parameters used for ARIMA were (2,1,0) for Mainland China, ARIMA(1,0,0) for South Korea, and ARIMA(3,1,0) for Thailand. Mainland China and Thailand were successful in haltering COVID-19 epidemic. Investigating their protocol in this control like quarantine should be in the first line of other countries’ programCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJohns Hopkins University Center for Systems Science and Engineering, 2019. https://github.com/CSSEGISandData/COVIDQ3 19/blob/master/time_series/time_series_2019-ncov-Confirmed.csv